Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Rating:
The Evidence Summary for this article has been prepared by the Cochrane Collaboration-a highly reputable, global, independent network of researchers, professionals, patients, carers and people interested in health.
You can click on 'Cochrane Summary,' which will open a new window on your screen and display the summary.